Search

everythinglearnresearchcommunity

for

Search:↓

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Hair follicles could help develop eye treatments by studying immune responses.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Coconut seed extract may effectively treat scabies in rabbits by killing mites and reducing inflammation.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Hair follicles help skin immune recovery after UVB exposure.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.